title: The role of leukotrienes in the late hemodynamic manifestations of group B streptococcal sepsis in piglets.
abstract: In order to evaluate the role of leukotrienes in group B streptococcal (GBS) sepsis we studied the effect of a leukotriene receptor antagonist, FPL 57231, on the late hemodynamic changes occurring secondary to an infusion of live GBS. Paralyzed, mechanically ventilated piglets received a continuous intravenous infusion of bacteria (5 x 10(7) org/kg/min) while systemic arterial (Psa) and pulmonary artery pressures (Ppa) were measured. To separate the effects of the lipoxygenase products of arachidonic acid from those of the cyclooxygenase by-products, animals in control and treatment groups received indomethacin, a cyclooxygenase blocking agent, 15 min after the infusion of GBS was begun. In addition to GBS and indomethacin, treatment animals received a 30 min infusion of FPL 57231 starting 120 min after the bacterial infusion was begun. All study animals responded to bacteria within 15 min with marked elevation in pulmonary artery pressure (X +/- SD) (12 +/- 3 to 49 +/- 5 mmHg; p less than .01), and a decline in PaO2 (84 +/- 9 to 49 +/- 5 mmHg; p less than .01) and cardiac output (0.29 +/- 0.04 to 0.18 +/- .07 liter/min/kg; p less than .01). These changes were reversed by indomethacin. Subsequent values remained relatively stable until approximately 90 min when a gradual decrease in cardiac output (CO) and PaO2, and an increase in Ppa, and calculated systemic (SVR) and pulmonary (PVR) vascular resistances occurred. After the initial increase in TxB2 and 6-keto-PGF1 alpha, indomethacin treatment resulted in return of these values to baseline with no further increase throughout the study period.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pediatrics (Division of Neonatology), University of Miami School of Medicine, Florida 33101.
authors.forename: R N
authors.initials: RN
authors.lastname: Goldberg
authors.forename: C
authors.initials: C
authors.lastname: Suguihara
authors.forename: O
authors.initials: O
authors.lastname: Martinez
authors.forename: A
authors.initials: A
authors.lastname: Bancalari
authors.forename: M R
authors.initials: MR
authors.lastname: Clark
authors.forename: E
authors.initials: E
authors.lastname: Bancalari
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002867:Chromones / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D018805:Sepsis / Q000097:blood / Q000503:physiopathology*; D013290:Streptococcal Infections / Q000097:blood / Q000503:physiopathology*; D013292:Streptococcus agalactiae; D013552:Swine; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D002867:Chromones; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C034338:FPL 57231